Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy

Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy

Vera Bril, Sasagu Tomioka, R. A. Buchanan et al. · Diabetic Medicine · 2009 · 220 citations · Full text

Medicine, Neurology, Neuroscience +16

Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes

New England Journal of Medicine · 2022 · 156 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study

Mamta Jaiswal, Catherine L. Martin, Morton B. Brown et al. · Journal of Diabetes and its Complications · 2015 · 88 citations · Full text

Medicine, Endocrinology, Pharmacology +13

Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats

Wei Jing Liu, Heung Yong Jin, Kyung Ae Lee et al. · British Journal of Pharmacology · 2011 · 82 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Diagnostic accuracy of nerve ultrasonography for the detection of peripheral neuropathy in type 2 diabetes

Roshan Dhanapalaratnam, Tushar Issar, Ann M. Poynten et al. · European Journal of Neurology · 2022 · 27 citations · Full text

Medicine, Internal Medicine, Neurology +16